Syndromes Involving Melanocytic Lesions


Many congenital syndromes are diagnosed with the aid of cutaneous findings. Certain medical conditions are detected early based on the appearance of premature, numerous, or abnormal skin lesions. The association of melanocytic nevi with specific syndromes is prominent with certain conditions and less consistent with others. Melanocytic nevi are fairly prevalent in the general population and often exhibit familial clustering; therefore, close attention must be paid to all associated findings in order to recognize the pattern of various syndromes and facilitate counseling and timely intervention.

This chapter describes syndromes associated with melanocytic nevi.


Malignant Peripheral Nerve Sheath Tumor Xeroderma Pigmentosum Melanocytic Nevus Carney Complex Sertoli Cell Tumor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Carney JA (1995) The Carney complex (myxomas, spotty pigmentation, endocrine overactivity and schwannomas). Dermatol Clin 13:19–25PubMedGoogle Scholar
  2. Bett BJ (2006) Large or multiple congenital melanocytic nevi: occurrence of neurocutaneous melanocytosis in 1008 persons. J Am Acad Dermatol 54:767–777PubMedCrossRefGoogle Scholar
  3. Bale SJ, Digiovanna JJ (2001) Cancer-associated genodermatosis and familial cancer syndromes with cutaneous manifestations. Clin Dermatol 19:284–289PubMedCrossRefGoogle Scholar
  4. Ball NJ, Kho GT (2005) Melanocytic nevi are associated with neurofibromas in neurofibromatosis, type I, but not sporadic neurofibromas. A study of 226 cases. J Cutan Pathol 32:523–532PubMedCrossRefGoogle Scholar
  5. Brasfield RD, Das Gupta TK (1972) Von Recklinghausen's disease: a clinicopathological study. Ann Surg 175:86–104PubMedCrossRefGoogle Scholar
  6. Kadonaga N, Frieden J (1991) Neurocutaneous melanosis. Definition and review of the literature. J Am Acad Dermatol 24:747–755PubMedCrossRefGoogle Scholar
  7. Moriwaki SI, Kraemer KH (2001) Xeroderma pigmentosum: bridging a gap between clinic and laboratory. Photodermatol Photoimmunol Photomed 17:47–54PubMedCrossRefGoogle Scholar
  8. Perera GK, Atherton D (2006) The value of MRI in a patient with occult spinal dysraphism. Pediatr Dermatol 23:24–26PubMedCrossRefGoogle Scholar
  9. Theos A, Korf B (2006) Pathophysiology of neurofibromatosis type 1. Ann Intern Med 144:842–849PubMedGoogle Scholar
  10. Wander JV, Das Gupta TK (1977) Neurofibromatosis. Curr Prob Surg 14:26–73Google Scholar
  11. Zahorcsek Z, Schneider I (1996) Generalized lentiginosis manifesting through three generations. Int J Dermatol 35:357–359PubMedCrossRefGoogle Scholar
  12. Crowe FW, Schull WJ, Neel JV (1956) A clinical, pathological and genetic study of multiple neurofibromatosis. Charles C. Thomas, Springfield, Ill., p. 181Google Scholar
  13. Atherton DJ, Pitcher DW, Wels RS et al. (1980) A syndrome of various cutaneous pigmented lesions, myxoid neurofibromatoma and atrial myxoma: the NAME syndrome. Br J Dermatol 103:421–429PubMedCrossRefGoogle Scholar
  14. Rhodes AR, Silverman RA, Harrist TJ et al. (1984) Mucocutaneous lentigines, cardiomucocutaneous myxomas, and multiple nlue nevi: the LAMB syndrome. J Am Acad Dermatol 10:72–82PubMedCrossRefGoogle Scholar
  15. Carney JA, Gordon, H, Carpenter PC et al. (1985) The complex of myxomas, spotty pigmentation, and endocrine overactivity. Medicine 64:270–283PubMedCrossRefGoogle Scholar
  16. Kraemer KH, Lee MM, Scotto J (1987) Xeroderma pigmentosum. Cutaneous, ocular and neurologic abnormalities in 830 published cases. Arch Dermatol 123:241–250PubMedCrossRefGoogle Scholar
  17. Bootsma D, Kraemer KH, Cleaver JE et al. Nucleotide excision repair syndromes: xeroderma pigmentosum, Cocakyne syndrome and trichothiodystrophy.Google Scholar
  18. Brophy JD, Sutton LN, Zimmerman RA et al. (1989) Magnetic resonance imaging of lipomyelomeningocele. Neurosurgery 25: 336–340PubMedCrossRefGoogle Scholar
  19. Gorlin RJ, Cohen MN, Levin LS (1990) Syndromes of the head and neck, 3rd edn. New York: Oxford University PressGoogle Scholar
  20. Byrd SE, Darling CF, Tomita T et al. (1991) MR imaging of symptomatic neurocutaneous melanosis in children. Pediatr Radiol 27:39–44CrossRefGoogle Scholar
  21. Cannon-Albright LA, Goldgar DE, Meyer LJ et al. (1992) Assignment of a locus for familial melanoma, MLM, to chromosome 9p13–p22. Science 258:1148–1152PubMedCrossRefGoogle Scholar
  22. Kadonaga N, Barkovich JA, Edwards MSB, Frieden IJ (1992) Neurocutaneous melanosis in association with the Dandy–Walker complex. Pediatr Dermatol 9:37–43PubMedGoogle Scholar
  23. Tucker MA, Fraser MC, Goldstein AM, et al. (1993) Risk of melanoma and other cancers in melanomaprone families. J Invest Dermatol 100 (Suppl):350s–355sPubMedCrossRefGoogle Scholar
  24. Ball NF, John JJ, Morelli JG et al. (1994) Ras mutations in human melanoma: a marker of malignant progression. J Invest Dermatol 102:285sCrossRefGoogle Scholar
  25. Davis DA, Cohen PR, George RE. (1994) Cutaneous stigmata of occult spinal dysraphism. J Am Acad Dermatol 31:892–896Google Scholar
  26. Goldstein AM, Fraser MC, Clark WHJ, Tucker MA (1994) Age at diagnosis and transmission of invasive melanoma in 23 families with cutaneous malignant melanoma/dysplastic nevi. J Natl Cancer Inst 86:1385–1390PubMedCrossRefGoogle Scholar
  27. Hussussian CJ, Struewing JP, Goldstein AM et al. (1994) Germline p16 mutations in familial melanoma. Nat Genet 8:15–21PubMedCrossRefGoogle Scholar
  28. Goldstein AM, Fraser MC, Struewing JP et al. (1995) Increased risk of pancreatic cancer in melanomaprone kindreds with p16 mutations. N Engl J Med 333:970–974PubMedCrossRefGoogle Scholar
  29. Chaloupka JC, Wolf RJ, Varma PK (1996) Neurocutaneous melanosis with the Dandy–Walker malformation: a possible rare pathoetiologic association. Neuroroadiology 38:486–489Google Scholar
  30. De David M, Orlow SJ, Provost N, et al. (1996) Neurocutaneous melanosis: clinical features of large congenital nevi in patients with manifest central nervous system melanosis. J Am Acad Dermatol 35:529–538CrossRefGoogle Scholar
  31. Casey M, Mah C, Merliss AD et al. (1998) Identification of a novel genetic loci for familial cardiac myxomas and Carney complex. Circulation 98:2560–2566PubMedGoogle Scholar
  32. Okulicz JF, Schwartz RA, Jozwiak S (2001) Lentigo. Cutis 67:367–370PubMedGoogle Scholar
  33. Abdelmalek NF, Gerber TL, Menter A (2002) Cardiocutaneous syndromes and associations. J Am Acad Dermatol 46:161–183PubMedCrossRefGoogle Scholar
  34. Evans DG, Baser ME, McGaughran J et al. (2002) Malignant peripheral nerve root sheath tumours in neurofibromatosis 1. J Med Genet 39:311–314PubMedCrossRefGoogle Scholar
  35. Mena-Cedillos CA, Valencia-Herrera AM, Arroyo-Pineda AI et al. (2002) Neurocutaneous melanosis in association with the Dandy–Walker complex, complicated by melanoma. Pediatr Dermatol 19:237–242PubMedCrossRefGoogle Scholar
  36. Itin PH, Burgdorf WH, Happle R et al. (2003) Genodermatosis. In: Schachner LA, Hansen RC (2003) Pediatric dermatology. Mosby, Elsevier Limited, PhiladelphiaGoogle Scholar
  37. Marghoob A, Borrego J, Halpern A (2003) Congential melanocytic nevi: treatment modalities and management options. Semin Cut Med Surg 22:21–32CrossRefGoogle Scholar
  38. Pollock PM, Harper UL, Hansen KS et al. (2003) High frequency of BRAF mutations in nevi. Nat Genet 33:19PubMedCrossRefGoogle Scholar
  39. Roco F di, Sabatino G, Koutzoglou M (2004) Neurocutaneous melanosis. Childs Nerv Syst 20:23–28CrossRefGoogle Scholar
  40. Guggisberg D, Hadj-Rabia S, Viney C et al. (2004) Skin markers of occult spinal dysraphism in children: a review of 54 cases. Arch Dermatol 140:1109–1115PubMedCrossRefGoogle Scholar
  41. Hale EK, Stein J, Ben-Porat L et al. (2005) Association of melanoma and neurocutaneous melanocytosis with large congenital melanocytic naevi: results from the NYU-LCMN registry. Br J Dermatol 152:512–517PubMedCrossRefGoogle Scholar
  42. Robinson AJ, Russell S, Rimmer S (2005) The value of ultrasonic examination of the lumbar spine in infants with specific reference to cutaneous markers of occult spinal dysraphism. Clin Radiol 60:72–77PubMedCrossRefGoogle Scholar
  43. Somoano B, Niendorf KB, Tsao H (2005) Hereditary cancer syndromes of the skin. Clin Dermatol 23:85–106PubMedCrossRefGoogle Scholar
  44. Marghoob AA, Dusza S, Oliveria S (2004) Number of Satellite Nevi as a Correlate for Neurocutaneous Melanocytic Nevi. Arch Dermatol 140:171-175.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2007

Personalised recommendations